In this issue:
Galectin-9 increases NK cell cytotoxicity in HCV infection
Scavenger receptor-AI+ macrophages limit hepatic damage
TDF ± FTC in lamivudine-resistant HBV infection
Elevated mortality rate in ‘‘cured” HCV-infected patients
Achieving SVR improves prognosis in cirrhotic HCV patients
Assessing intra-hepatic HCV compartmentalisation
Sofosbuvir-daclatasvir in genotype 1 HCV infection
Time trends of chronic HBV infection over prior decades
Insights into HCV cell entry and liver disease
Elbasvir/grazoprevir ± ribavirin in treatment-experienced HCV
Please login below to download this issue (PDF)